Liver cancer, more specifically hepatocellular carcinoma (HCC), is the second leading
cause of cancer-related death and its incidence is increasing globally. Around 50% of …

The liver is the sixth most common site of primary cancer in humans and the fourth leading
cause of cancer‐related death in the world. Hepatocellular carcinoma (HCC) accounts for …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths in
the world. Metabolic reprogramming is considered a new hallmark of cancer, but it remains …

Natural killer (NK) cells account for 25–50% of the total number of hepatic lymphocytes,
which implicates that NK cells play an important role in liver immunity. The frequencies of …

Lung cancer is the leading cause of cancer-related death worldwide. Although natural killer
(NK) cells are garnering interest as a potential anticancer therapy because they selectively …

Hepatocellular carcinoma (HCC) is a typical inflammation‐induced cancer and displays a
complex interaction between the tumor microenvironment and tumor development. Immune …

Natural killer (NK) cells are lymphocytes with potent antitumor functions and, consequently,
several NK cell-based strategies have been developed for cancer immunotherapy. A …

Natural killer (NK) cells are lymphocytes with potent antitumor functions and, therefore,
multiple NK cell-based cancer immunotherapies have been developed and are currently …

Conclusions: We show that HCV-related HCC development has profound effects on the
imprint of NK cells. Persistent co-expression of TIM-3hi and CD38+ on NK cells is an early …

Liver cancer including hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (iCCA) is the third leading cause of cancer-related deaths worldwide …